The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
How the ageing microenvironment influences tumour progression
Open accessAbstract
Most cancers arise in individuals over the age of 60. As the world population is living longer and reaching older ages, cancer is becoming a substantial public health problem. It is estimated that, by 2050, more than 20% of the world's population will be over the age of 60 - the economic, healthcare and financial burdens this may place on society are far from trivial. In this Review, we address the role of the ageing microenvironment in the promotion of tumour progression. Specifically, we discuss the cellular and molecular changes in non-cancerous cells during ageing, and how these may contribute towards a tumour permissive microenvironment; these changes encompass biophysical alterations in the extracellular matrix, changes in secreted factors and changes in the immune system. We also discuss the contribution of these changes to responses to cancer therapy as ageing predicts outcomes of therapy, including survival. Yet, in preclinical studies, the contribution of the aged microenvironment to therapy response is largely ignored, with most studies designed in 8-week-old mice rather than older mice that reflect an age appropriate to the disease being modelled. This may explain, in part, the failure of many successful preclinical therapies upon their translation to the clinic. Overall, the intention of this Review is to provide an overview of the interplay that occurs between ageing cell types in the microenvironment and cancer cells and how this is likely to impact tumour metastasis and therapy response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the accumulation of genomic mutations over time, age-related cellular senescence also contributes to cancer development and progression (2).”
From Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“SASP has been linked to the aggressiveness of certain cancers (2, 10).”
From Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment (2023) · cites this paper as [2]
In the citing paper
“However, the main obstacle to achieving efficacious immunotherapy is the tumor microenvironment (TME), which may accelerate senescence of the immune system [18, 19]: potential targets for rejuvenating the immune system are still a hypothesis.”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [18]
In the citing paper
“Furthermore, in aging TME, changes in immune cell function and secretion of SASP molecules dramatically affect tumor progression [18].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [18]
In the citing paper
“Finally, emerging evidence suggests that the aging microenvironment largely contributes to age-related decline in immune function and may also provide potential targets for rejuvenating the immune system [18].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [18]
In the citing paper
“as well as due to biophysical alterations of the extracellular matrix that affect the mobility and placement of immune effectors.261”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [261]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670
Cited by
Sorted by citations
Items 101–200 of 854
Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly
Shive, C. L., & Pandiyan, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.840827 · Cited by 59
The extracellular matrix in cancer: from understanding to targeting
Chitty, J. L., & Cox, T. R. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.05.003 · Cited by 56
Wang, Y., Jiang, M., Zhu, J., Qu, J., Qin, K., Zhao, D., Wang, L., Dong, L., & Zhang, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110797 · Cited by 54
Gut microbiome–immune system interaction in reptiles
Siddiqui, R., Maciver, S. K., & Khan, N. A. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15438 · Cited by 58
The role of cellular senescence in ovarian aging
Hense, J. D., Isola, J. V. V., Garcia, D. N., Magalhães, L. S., Masternak, M. M., Stout, M. B., & Schneider, A. (2024) · npj Aging · doi:10.1038/s41514-024-00157-1 · Cited by 65
Cell Adhesion Molecules in Plasticity and Metastasis
Smart, J. A., Oleksak, J. E., & Hartsough, E. J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0595 · Cited by 56
Senescent cell accumulation mechanisms inferred from parabiosis
Karin, O., & Alon, U. (2021) · GeroScience · doi:10.1007/s11357-020-00286-x · Cited by 48
Mandelblatt, J. S., Ahles, T. A., Lippman, M. E., Isaacs, C. J., Adams-Campbell, L. L., Saykin, A. J., Cohen, H. J., & Carroll, J. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1160 · Cited by 53
Preclinical models for drug discovery for metastatic disease
Wakefield, L. M., Agarwal, S., & Tanner, K. (2023) · Cell · doi:10.1016/j.cell.2023.02.026 · Cited by 55
Sapudom, J., Alatoom, A., Tipay, P. S., & Teo, J. C. M. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122900 · Cited by 55
Luo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 61
Chen, W., Altshuler, R. D., Daschner, P., Salvador-Morales, C., Germain, D. S., Guida, J., Prasanna, P. G. S., & Buchsbaum, J. C. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae163 · Cited by 63
Nasim, M. J., Zuraik, M. M., Abdin, A. Y., Ney, Y., & Jacob, C. (2021) · Antioxidants · doi:10.3390/antiox10060882 · Cited by 52
Bahçecioğlu, G., Yue, X. S., Howe, E. N., Guldner, I. H., Stack, M. S., Nakshatri, H., Zhang, S., & Zorlutuna, P. (2021) · Advanced Science · doi:10.1002/advs.202100128 · Cited by 52
Liu, Q., Li, J., Sun, X., Lin, J., Yu, Z., Xiao, Y., Li, D., Sun, B., Bao, H., & Liu, Y. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01735-w · Cited by 57
The neglected brothers come of age: B cells and cancer
Shalapour, S., & Karin, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101479 · Cited by 51
Targeting the stem cell niche micro-environment as therapeutic strategies in aging
Farahzadi, R., Valipour, B., Montazersaheb, S., & Fathi, E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1162136 · Cited by 51
The complex interplay between aging and cancer
Trastus, L. A., & di Fagagna, F. D. (2025) · Nature Aging · doi:10.1038/s43587-025-00827-z · Cited by 56
Denk, D., Singh, A., Kasler, H. G., D’Amico, D., Rey, J., Alcober-Boquet, L., Gorol, J. M., Steup, C., Tiwari, R., Kwok, R., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00996-x · Cited by 58
Dong, L., Li, W., Yu, L., Sun, L., Chen, Y., & Hong, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12948 · Cited by 50
Hutchinson, A. N., Bergh, C., Krüger, K., Sűsserová, M., Allen, J., Améen, S., & Tingö, L. (2021) · Microorganisms · doi:10.3390/microorganisms9061344 · Cited by 59
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice
Zhang, C., Lei, L., Yang, X., Ma, K., Zheng, H., Su, Y., Jiao, A., Wang, X., Liu, H., Zou, Y., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002809 · Cited by 50
Du, M., Sun, L., Guo, J. J., & Lv, H. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107198 · Cited by 51
Ageing, immune fitness and cancer
Dolan, M., Libby, K. A., Ringel, A. E., van Galen, P., & McAllister, S. S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00858-z · Cited by 55
Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
Ginefra, P., Lorusso, G., & Vannini, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124441 · Cited by 48
Delineating the evolutionary dynamics of cancer from theory to reality
Božić, I., & Wu, C. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0079-6 · Cited by 46
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia
Zhang, Y., Li, Z., Huang, Y., Zou, B., & Xu, Y. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258786 · Cited by 46
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance
Peng, J., Yin, X., Yun, W., Meng, X., & Huang, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216108 · Cited by 46
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Chu, Z., Wang, W., Zheng, W., Fu, W., Wang, Y., Wang, H., & Qian, H. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00636d · Cited by 45
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
Bishoyi, A. K., Nouri, S., Hussen, A., Bayani, A., Khaksari, M. N., & Samarkhazan, H. S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01686-z · Cited by 48
The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression
Worrede, A., Douglass, S. M., & Weeraratna, A. T. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143763 · Cited by 47
Self-citationWang, S., Zhou, X., Zeng, Z., Sui, M., Chen, L., Feng, C., Huang, C. Y., Yang, Q., Ji, M., & Hou, P. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01034-9 · Cited by 43
Age-related decline in CD8+ tissue resident memory T cells compromises antitumor immunity
Pei, S., Deng, X., Yang, R., Wang, H., Shi, J., Wang, X., Huang, J., Tian, Y., Wang, R., Zhang, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00746-5 · Cited by 43
Deconstructing tumor heterogeneity: the stromal perspective
Vickman, R. E., Faget, D. V., Beachy, P. A., Beebe, D. J., Bhowmick, N. A., Cukierman, E., Deng, W.-M., Granneman, J. G., Hildesheim, J., Kalluri, R., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27736 · Cited by 43
Self-citationActivatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz‐Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 41
Tian, G., Li, R., Cui, Y., Zhou, T., Shi, Y., Yang, W., Ma, Y., Shuai, J., & Yan, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980465 · Cited by 42
Key promoters of tumor hallmarks
Mortezaee, K., & Majidpoor, J. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02074-9 · Cited by 42
Wang, X., Luo, Y., He, S., Lu, Y., Gong, Y., Gao, L. P., Mao, S., Liu, X., Jiang, N., Pu, Q., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00572-9 · Cited by 43
Alves, I., Araújo, E. M. Q., Dalgaard, L. T., Singh, S. P., Børsheim, E., & Carvalho, E. (2025) · Nutrients · doi:10.3390/nu17030428 · Cited by 45
Chen, Y., Meng, Z., Zhang, L., & Liu, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664845 · Cited by 42
Filho, R. I., Ochioni, A. C., Esteves, A. M., Leandro, J. G. B., Demaria, T. M., Sola‐Penna, M., & Zancan, P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03929-9 · Cited by 41
Helicobacter pylori ‐positive chronic atrophic gastritis and cellular senescence
Zheng, S., Zhu, L., Wu, L., Liu, H., Ma, X., Li, Q., Wu, M., Wang, W., Li, J., & Wu, H. (2022) · Helicobacter · doi:10.1111/hel.12944 · Cited by 42
Metabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42
Landre, T., Guetz, G. D., Chouahnia, K., Fossey-Diaz, V., & Culine, S. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00788-5 · Cited by 42
Quan, T., Xia, W., He, T., Calderone, K., Bou–Gharios, G., Voorhees, J. J., Dlugosz, A. A., & Fisher, G. J. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.02.028 · Cited by 43
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Li, Z., & Yin, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188997 · Cited by 44
Collagen IV differentially regulates planarian stem cell potency and lineage progression
Chan, A., Ma, S., Pearson, B. J., & Chan, D. T.-M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021251118 · Cited by 42
Meng, Q., Luo, X., Chen, J., Wang, D., Chen, E., Zhang, W., Zhang, G., Zhou, W., Xu, J., & Song, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188443 · Cited by 38
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging
Noll, J. H., Levine, B. L., June, C. H., & Fraietta, J. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101840 · Cited by 41
Role of myeloid-derived suppressor cells in metastasis
Cole, K., Pravoverov, K., & Talmadge, J. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09947-x · Cited by 38
Zhu, H., Hu, X., Feng, S., Jian, Z., Xu, X., Gu, L., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6419695 · Cited by 44
T-cell dysfunctions in myelodysplastic syndromes
Rodríguez‐Sevilla, J. J., & Colla, S. (2024) · Blood · doi:10.1182/blood.2023023166 · Cited by 37
Wakkerman, F. C., Wu, J., Putter, H., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., Haverkort, M. A. D., de Jong, M., Mens, J. W., Wortman, B. G., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00142-6 · Cited by 37
Single-cell transcriptional atlas of tumor-associated macrophages in breast cancer
Zhang, Y., Zhong, F., & Liu, L. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01887-6 · Cited by 43
Kao, C., Charmsaz, S., Tsai, H., Aziz, K., Shu, D. H., Munjal, K., Griffin, E., Leatherman, J. M., Lipson, E. J., Ged, Y. M. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58512-z · Cited by 37
Fane, M. E., Ecker, B. L., Kaur, A., Marino, G. E., Alicea, G. M., Douglass, S. M., Chhabra, Y., Webster, M. R., Marshall, A., Colling, R. T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0446 · Cited by 38
Self-citationDecoding and rejuvenating human ageing genomes: Lessons from mosaic chromosomal alterations
Dai, X., & Guo, X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101342 · Cited by 39
Sun, L., Ke, M.-L., Wang, X., Yin, M., Wei, J., Xu, L., Tian, X., Wang, F., Zhang, H., Fu, S., et al. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23445 · Cited by 40
Hamilton, J. A. G., Lee, M., Hunter, R., Ank, R. S., Story, J. Y., Talekar, G. R., Sisroe, T., Ballak, D. B., Fedanov, A., Porter, C. C., et al. (2021) · Aging Cell · doi:10.1111/acel.13309 · Cited by 37
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
Zabransky, D. J., Chhabra, Y., Fane, M. E., Kartalia, E., Leatherman, J. M., Hüser, L., Zimmerman, J. W., Delitto, D., Han, S., Armstrong, T. D., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0086 · Cited by 38
Self-citationTian, Y., Cheng, T., Sun, F., Zhou, Y., Yuan, C., Guo, Z., & Wang, Z. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103124 · Cited by 38
Chen, J., Wang, Y., Zhang, W., Zhao, D., Zhang, L., Zhang, J., Fan, J., & Zhan, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.472 · Cited by 36
Immunosenescence and cancer: Opportunities and challenges
Fu, Z., Xu, H., Yue, L., Zheng, W., Pan, L., Gao, F., & Liu, X. (2023) · Medicine · doi:10.1097/md.0000000000036045 · Cited by 37
Meguro, S., Johmura, Y., Wang, T., Kawakami, S., Tanimoto, S., Omori, S., Okamura, Y. T., Hoshi, S., Kayama, E., Yamaguchi, K., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00704-1 · Cited by 37
Old Stars and New Players in the Brain Tumor Microenvironment
Parmigiani, E., Scalera, M., Mori, E., Tantillo, E., & Vannini, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.709917 · Cited by 34
Nuclear Sirtuins and the Aging of the Immune System
Gámez-García, A., & Vázquez, B. N. (2021) · Genes · doi:10.3390/genes12121856 · Cited by 36
Stromal lipid species dictate melanoma metastasis and tropism
Gurung, S., Budden, T., Mallela, K., Jenkins, B., von Kriegsheim, A., Manrique‐Silva, E., Millán-Esteban, D., Romero-Camarero, I., Amaral, F. M. R., Craig, S., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.04.001 · Cited by 37
Impact of tumor-parenchyma biomechanics on liver metastatic progression: a multi-model approach
Wang, Y., Brodin, E., Nishii, K., Frieboes, H. B., Mumenthaler, S. M., Sparks, J. L., & Macklin, P. (2021) · Scientific Reports · doi:10.1038/s41598-020-78780-7 · Cited by 37
Animal models of brain metastasis
Miarka, L., & Valiente, M. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab115 · Cited by 37
Chen, X., Mo, S., & Yi, B. (2022) · BMC Public Health · doi:10.1186/s12889-022-13281-y · Cited by 33
van Bree, N. F. H. N., & Wilhelm, M. (2022) · Cancers · doi:10.3390/cancers14205009 · Cited by 32
Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Bennink, H. J. T. C., Schultz, I. J., Schmidt, M., Jordan, V. C., Briggs, P., Egberts, J. F. M., Gemzell‐Danielsson, K., Kiesel, L., Kluivers, K. B., Krijgh, J., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01661-0 · Cited by 34
Zhang, M., Cui, J., Chen, H., Cheng, Y., Chen, Q., Zong, F., Lu, X. J., Qin, L., Han, Y., Kuai, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56002-w · Cited by 37
Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside
Wang, Z., Wang, M., Dong, B., Wang, Y., Ding, Z., & Shen, S. (2025) · Nature Communications · doi:10.1038/s41467-025-66376-6 · Cited by 46
Obesity and visceral fat: Survival impact in high-grade endometrial cancer
Donkers, H., Fasmer, K. E., McGrane, J., Pijnenborg, J. M. A., Bekkers, R. L. M., Haldorsen, I. S., & Galaal, K. A. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.11.050 · Cited by 36
Yamada, K., Oikawa, T., Kizawa, R., Motohashi, S., Yoshida, S., Kumamoto, T., Saeki, C., Nakagawa, C., Shimoyama, Y., Aoki, K., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2009 · Cited by 32
Cells with cancer‐associated mutations overtake our tissues as we age
Evans, E. J., & DeGregori, J. V. (2021) · Aging and Cancer · doi:10.1002/aac2.12037 · Cited by 35
Zhang, J., & Shi, Y. (2022) · Cells · doi:10.3390/cells11121906 · Cited by 34
Impact of Age-, Cancer- and Treatment-Driven Inflammation on T Cell Function and Immunotherapy
Quinn, K. M., Kartikasari, A. E. R., Cooke, R. E., Koldej, R. M., Ritchie, D. S., & Plebanski, M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0520-466r · Cited by 31
Challenges of Survivorship for Older Adults Diagnosed with Cancer
Fitch, M. I., Nicoll, I., Newton, L. J., & Strohschein, F. J. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01255-7 · Cited by 33
CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
Mortezaee, K., & Majidpoor, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864298 · Cited by 34
Reprogramming of tissue metabolism during cancer metastasis
Ganguly, K., & Kimmelman, A. C. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.02.005 · Cited by 32
Garófolo, A., Qiao, L., & Maia-Lemos, P. D. S. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1797126 · Cited by 30
Ding, X., Ma, X., Meng, P., Yue, J., Li, L., & Xu, L. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s447514 · Cited by 33
The role of host environment in cancer evolution
Solary, É., & Laplane, L. (2020) · Evolutionary Applications · doi:10.1111/eva.13039 · Cited by 33
CISD2 plays a role in age-related diseases and cancer
Liao, H.-Y., Liao, B., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111472 · Cited by 33
Huang, Y., Hou, M., Tsai, Y., Pan, Y., Tsai, P.-H., Lin, Y.-S., Chang, C., Tsai, E., & Hsu, Y. (2023) · Cellular Oncology · doi:10.1007/s13402-022-00767-5 · Cited by 30
Duan, R., Jiang, L., Wang, T., Li, Z., Yu, X., Gao, Y., Jia, R., Fan, X., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-55164-3 · Cited by 33
Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation
Han, H.-M., Kim, S.-Y., & Kim, D. (2025) · APL Bioengineering · doi:10.1063/5.0263236 · Cited by 30
Epidemiology of Anthropometric Factors in Glioblastoma Multiforme—Literature Review
Simińska, D., Korbecki, J., Kojder, K., Kapczuk, P., Fabiańska, M., Gutowska, I., Machoy‐Mokrzyńska, A., Chlubek, D., & Baranowska‐Bosiacka, I. (2021) · Brain Sciences · doi:10.3390/brainsci11010116 · Cited by 29
Lee, J.-H., Lee, D., Lawler, S. E., & Kim, Y. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008257 · Cited by 31
Liang, Z., Pan, L., Shi, J., & Zhang, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-24353-9 · Cited by 30
Wang, H., Yu, Y., Li, R., Zhang, H., Chen, Z., Sun, C., & Zhuang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.022 · Cited by 36
Youn, B.-Y., Lee, S.-Y., Cho, W., Bae, K.-R., Ko, S., & Cheon, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074165 · Cited by 28
A pan-cancer analysis of the oncogenic role of leucine zipper protein 2 in human cancer
Feng, D., Shi, X., Zhu, W., Zhang, F., Li, D., Han, P., Wei, Q., & Yang, L. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00313-x · Cited by 28
Role of myeloid-derived suppressor cells in tumor recurrence
Cole, K., Al-Kadhimi, Z. S., & Talmadge, J. E. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10079-1 · Cited by 30
Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer
Jingyuan, L., Liu, Y., Jiang, H., Wang, T., Li, K., Lao, X., Guiqing, L., & Yujie, L. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101681 · Cited by 27
Aging and immunotherapies: New horizons for the golden ages
Hamilton, J. A. G., & Henry, C. J. (2020) · Aging and Cancer · doi:10.1002/aac2.12014 · Cited by 28
An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma
Zhang, W., Li, Y., Lyu, J., Shi, F., Kong, Y., Sheng, C., Wang, S., & Wang, Q. (2021) · Cancer Science · doi:10.1111/cas.15254 · Cited by 26
Cancer Burden in China during 1990–2019: Analysis of the Global Burden of Disease
Zhang, S., Zhang, L., & Xie, L. (2022) · BioMed Research International · doi:10.1155/2022/3918045 · Cited by 27
Metadata
- Authors
- Fane, M., & Weeraratna, A. T.
- Affiliations
- The Wistar Institute (US)
- Corresponding author
- Fane, Mitchell
- Weeraratna, Ashani T.
- Venue
- Nature Reviews Cancer
- Published
- 2019-12-13
- Volume
- 20
- Issue
- 2
- Pages
- 89-106
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC7377404
- OpenAlex
- W2995607278
- Cited by
- 849
- References
- 228
- Citations by year
- 2026: 109 · 2025: 176 · 2024: 166 · 2023: 130 · 2022: 122 · 2021: 92 · 2020: 54
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA207935, P01CA114046, R01CA174746, R01CA232256, P30CA010815, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- tumor microenvironment, aging, tumor progression, extracellular matrix, secreted factors, cancer therapy response, tumour metastasis, preclinical mouse models
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Combined Modality Therapy, Extracellular Matrix, Humans, Neoplasms, Treatment Outcome, Stromal Cells, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
